Key Takeaways
- In the first randomized trial of its kind, 120 adults on tirzepatide lost the same amount of fat whether or not they lifted weights — but the training group kept about 1.1 kg more
- Strength diverged sharply: bench press rose 10.7% with training while falling 8.4% on the drug alone, with the same pattern in lat pulldown and knee extension.
- The program was demanding — three supervised resistance sessions a week — and the trial enrolled men and postmenopausal women without diabetes, so results may not map to every user
The weight came off either way. The muscle didn't have to.
Weight-loss drugs can shrink fat and strength. This trial found a way to fight back.
Imagine two people taking the same weight-loss drug. Both lose a similar amount of fat. But when they finish, one has lost strength. The other can lift more than when they started.
That is what happened in a randomized trial published in Nature Medicine. And the difference came down to resistance training.
The T-REx trial enrolled 120 adults — men and postmenopausal women, with an average age of about 58. Most had obesity, and none had diabetes. Everyone took tirzepatide for 40 weeks. Half also completed three supervised resistance-training sessions every week.
The commitment was substantial: participants attended an average of 91% of their scheduled training sessions. About 93% of all participants completed the trial.
The fat loss was the same. The muscle loss wasn't.
Both groups lost statistically indistinguishable amounts of fat.
But the group taking tirzepatide without resistance training lost 4.67 kg of lean soft tissue. Those who also trained lost 3.57 kg.
That's approximately 1.1 kg less lean tissue lost, or roughly 24% less than the drug-only group.
Then came the more striking result.
One group lost strength. The other gained it.
Among participants taking tirzepatide without resistance training:
- Bench press strength fell 8.4%.
- Lat pulldown strength fell 6.5%.
- Knee extension strength fell 9.0%.
In the resistance-training group, all three measures moved in the opposite direction:
- Bench press strength increased 10.7%.
- Lat pulldown strength increased 15.7%.
- Knee extension strength increased 17.5%.
Same medication. Similar fat loss. Very different strength outcomes.
There are important limitations. This was a trial of just 120 people, involving a supervised exercise program with high attendance. Participants did not have diabetes, and the results cannot automatically be applied to everyone taking tirzepatide or other weight-loss medications.
But the findings offer something important: resistance training may help people lose weight without sacrificing as much lean tissue or strength.
The Twikup Take
Weight loss is not just about what disappears from the scale. It's also about what remains when the weight comes off.
The goal shouldn't just be to become lighter. It should be to become lighter without becoming weaker.
This article is general information, not medical advice. Talk to your own doctor before changing medication or starting a new exercise program, especially with a health condition.
Image: Illustrative image.